MedPath

MEMORIAL HERMANN HEALTH SYSTEM

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:4
Completed:0

Trial Phases

3 Phases

Phase 1:1
Phase 2:2
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (40.0%)
Phase 2
2 (40.0%)
Phase 1
1 (20.0%)

Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose

Phase 1
Not yet recruiting
Conditions
Acute Ischemic Stroke
Interventions
First Posted Date
2025-01-30
Last Posted Date
2025-06-05
Lead Sponsor
Memorial Hermann Health System
Target Recruit Count
20
Registration Number
NCT06801054
Locations
🇺🇸

Memorial Hermann Hospital, Houston, Texas, United States

Verticalization Robotic Exoskeleton DoC

Not Applicable
Conditions
Brain Injuries
Disorder of Consciousness
First Posted Date
2021-04-06
Last Posted Date
2021-09-01
Lead Sponsor
Memorial Hermann Health System
Target Recruit Count
10
Registration Number
NCT04833543
Locations
🇺🇸

TIRR Memorial Hermann, Houston, Texas, United States

Mood Tracker Smartphone App for Management of Emotional Distress After TBI

Phase 2
Conditions
Emotional Distress
First Posted Date
2020-06-01
Last Posted Date
2020-09-02
Lead Sponsor
Memorial Hermann Health System
Target Recruit Count
126
Registration Number
NCT04410770
Locations
🇺🇸

Memorial Hermann Hospital-Texas Medical Center, Houston, Texas, United States

Cardiovascular Manifestations of COVID-19

Conditions
Cardiovascular Diseases
COVID
First Posted Date
2020-04-06
Last Posted Date
2020-04-07
Lead Sponsor
Memorial Hermann Health System
Target Recruit Count
500
Registration Number
NCT04335630
Locations
🇺🇸

Memorial Hermann Hospital-Texas Medical Center, Houston, Texas, United States

Almond Effects on Glucose Intolerance Study

Not Applicable
Terminated
Conditions
Prediabetes
First Posted Date
2014-10-09
Last Posted Date
2024-03-20
Lead Sponsor
Memorial Hermann Health System
Target Recruit Count
24
Registration Number
NCT02260895
Locations
🇺🇸

Physicians at Sugar Creek - Memorial Family Medicine Residency Program, Sugar Land, Texas, United States

  • Prev
  • 1
  • 2
  • Next

News

UPMC Enterprises Leads $18.25 Million Series B1 Investment in Carta Healthcare for AI-Powered Clinical Data Management

UPMC Enterprises has led an $18.25 million Series B1 funding round for Carta Healthcare, with participation from multiple strategic healthcare investors including MemorialCare Innovation Fund and Rex Health Ventures.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.